Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

15 projects found matching your search criteria :

  1. Coating dextran nanocarriers with immune cell membranes as a way to transport active substances across the blood-brain b...

    Call: PRELUDIUM 23 , Panel: ST11

    Principal investigator: Daniel Filip Wyleziński

    Politechnika Warszawska

  2. Manufacture of a new generation three-dimensional "drug-on-chip" materials with controlled release of active agents dedi...

    Call: SONATINA 8 , Panel: ST8

    Principal investigator: dr Wiktoria Dominika Tomal

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  3. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

  4. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  5. Structure and Function of Protein Corona at the Nanoparticles Interface

    Call: OPUS 21 , Panel: ST5

    Principal investigator: prof. Barbara Dorota Jachimska

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  6. Towards the integrated molecular modelling – machine learning (MM-ML)" computational method for supporting the design of...

    Call: SHENG 2 , Panel: ST5

    Principal investigator: prof. Tomasz Puzyn

    Uniwersytet Gdański, Wydział Chemii

  7. Polymersomes specifically releasing cGAMP and doxorubicin in tumor hypoxic regions as a new anti-cancer therapeutic stra...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: dr hab. Ryszard Smolarczyk

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  8. Modulation of immune cells activity in the tumor microenvironment by oligonucleotide therapeutics delivered by silk nano...

    Call: OPUS 19 , Panel: NZ6

    Principal investigator: prof. Hanna Dams-Kozłowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  9. Modified glycosaminoglycans as nanocarriers of bioactive substances

    Call: OPUS 18 , Panel: ST5

    Principal investigator: dr hab. Mariusz Kępczyński

    Uniwersytet Jagielloński, Wydział Chemii

  10. Theranostic nanocarriers for drug delivery in central nervous system disorders

    Call: GRIEG 1 , Panel: ST5

    Principal investigator: prof. Piotr Warszyński

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  11. Synthesis of biopolimer-based hybrid nanoparticles

    Call: PRELUDIUM 12 , Panel: ST5

    Principal investigator: Marta Anna Szczęch

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  12. New nanocarriers of curcumin as a kind of "pro-drug" - physicochemical characteristics and biological characteristics on...

    Call: PRELUDIUM 5 , Panel: ST5

    Principal investigator: dr Dorota Lachowicz

    Uniwersytet Jagielloński, Wydział Chemii

  13. Oligosilsesquioxane drug nanocarriers

    Call: OPUS 4 , Panel: ST5

    Principal investigator: dr hab. Włodzimierz Andrzej Stańczyk

    Centrum Badań Molekularnych i Makromolekularnych PAN

  14. Injectable and implantable biomaterials with drug delivery spherical micro/nanocarriers for the treatment of bone diseas...

    Call: OPUS 3 , Panel: ST8

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

  15. Targeted drug delivery systems - synthesis and functionalization of nanocarriers

    Call: SONATA 2 , Panel: ST5

    Principal investigator: dr Krzysztof Szczepanowicz

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN